About Urica Therapeutics
Urica Therapeutics is a private company based in Bay Harbor Islands, Florida. It has reported $2,533,350 raised in one offering on Form D since January 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 27, 2022 | Jan 5, 2023 | $2,533,350of $5.0M target | 26 | $97,437 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Urica Therapeutics's Form D filed Jan 5, 2023.
RZ
Raymond Zheng
Executive officer and director
JD
Jay Kranzler, M.D., Ph.D.
Executive officer and director
MW
Michael Weiss
Director
VD
Vibeke Strand, M.D.
Director
LD
Lindsay Rosenwald, M.D.
Director